Ventio participates to the follow-up of Alzheimer’s disease patients by offering a patented, innovative and quantitative technology for the follow-up[…]
Read moreAuthor: Stephane
Eurobiomed, #HEALTHTECH IN SOUTH OF FRANCE
Marseille Innovation
Institut Régional des Chefs d’Entreprise
La French Tech Aix Marseille
SATT Sud Est, THE TECHNOLOGY TRANSFER ACCELERATOR
Numeum, Companies changing the world
QSM as an imaging biomarker for Alzheimer’s disease
Quantitative susceptibility mapping as an imaging biomarker for Alzheimer’s disease: The expectations and limitations Yuto Uchida, Hirohito Kan, Keita Sakurai,[…]
Read moreSENIOR cohort : imaging the aging brain
Imaging the aging brain: study design and baseline findings of the SENIOR cohort Alexa Haeger, Jean-François Mangin, Alexandre Vignaud, Cyril[…]
Read more